Correlation Between Artelo Biosciences and BioCardia
Can any of the company-specific risk be diversified away by investing in both Artelo Biosciences and BioCardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artelo Biosciences and BioCardia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artelo Biosciences and BioCardia, you can compare the effects of market volatilities on Artelo Biosciences and BioCardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artelo Biosciences with a short position of BioCardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artelo Biosciences and BioCardia.
Diversification Opportunities for Artelo Biosciences and BioCardia
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Artelo and BioCardia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Artelo Biosciences and BioCardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioCardia and Artelo Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artelo Biosciences are associated (or correlated) with BioCardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioCardia has no effect on the direction of Artelo Biosciences i.e., Artelo Biosciences and BioCardia go up and down completely randomly.
Pair Corralation between Artelo Biosciences and BioCardia
If you would invest (100.00) in BioCardia on December 30, 2024 and sell it today you would earn a total of 100.00 from holding BioCardia or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Artelo Biosciences vs. BioCardia
Performance |
Timeline |
Artelo Biosciences |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
BioCardia |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Artelo Biosciences and BioCardia Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Artelo Biosciences and BioCardia
The main advantage of trading using opposite Artelo Biosciences and BioCardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artelo Biosciences position performs unexpectedly, BioCardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCardia will offset losses from the drop in BioCardia's long position.Artelo Biosciences vs. Eyenovia | Artelo Biosciences vs. Arrowhead Pharmaceuticals | Artelo Biosciences vs. Krystal Biotech | Artelo Biosciences vs. BioNTech SE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |